Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report
Cytomegalovirus (CMV) infection is a common complication in patients undergoing hematopoietic stem cell transplantation (HSCT). Management of refractory CMV infections, especially in developing countries, can be challenging due to the limited availability of second and third-line antiviral drugs or...
Main Authors: | Alejandra Pando-Caciano, Ketty Adid Escudero-Ramirez, Jackeline Carol Torres-Rodríguez, Holger Maita-Malpartida |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1335969/full |
Similar Items
-
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
by: Lauren A. Sadowski, et al.
Published: (2021-06-01) -
Resistance to antiviral drugs in human viruses from the subfamily <i>Betaherpesvirinae</i>
by: Mikhail V. Demin, et al.
Published: (2022-11-01) -
Monitoring of resistanceassociated mutations in UL97 gene of cytomegalovirus in children after allogeneic hematopoietic stem cell transplantation
by: Kozhushnaya O.S., et al.
Published: (2022-03-01) -
In vitro activity of six antiviral drugs against equid alphaherpesvirus type 1 indicates ganciclovir as promising drug for in vivo studies
by: Amanda Lovato de Oliveira, et al.
Published: (2018-12-01) -
A preliminary study on the UL97 gene of cytomegalovirus isolated from patients suspected of ganciclovir resistance in Sri Lanka
by: J. C. Thambyrajah, et al.
Published: (2023-04-01)